Last month, a contract between the Germany based trading company ABCR, one of the leading providers of research chemicals, and ChiroBlock was signed. This agreement grants ABCR an exclusive and world wide right to sell research quantities of a selection of ChiroBlock’s compounds resulting from own research projects.

This new partnership will effectively support the worldwide marketing of our newly developed – mainly chiral – building blocks. It is a consequent step in accordance with ChiroBlock’s policy to entirely focus on synthetic research and development.